Plasminogen Activator Release During Venous Stasis and Exercise As Determined by a New Specific Assay
Overview
Authors
Affiliations
A method for the specific determination of tissue plasminogen activator in plasma samples has been developed. The method is based on a recently described parabolic rate assay for tissue plasminogen activator (Rånby and Wallén, 1980) measuring plasmin activity by a chromogenic tripeptide-paranitroanilide substrate. The potential interference by plasmin inhibitors in plasma is overcome by acidification of the plasma samples to pH 4 for 15 min prior to the analysis. The baseline activity (after 10 min of rest) in 22 healthy individuals was determined to be 0.05 +/- 0.03 (SD) IU/ml (0.2 +/- 0.1 ng/ml). After venous occlusion for 10 min at 100 mm Hg the activator concentrations had increased to 1.2 +/- 1.2 (SD) IU/ml (5.2 +/- 5.2 ng/ml). Furthermore, prior to venous occlusion almost no plasmin-alpha 2-antiplasmin complex was found in the samples, whereas a pronounced increase in this complex was noted in 90% of the subjects after venous occlusion. During exercise, a gradual work-load dependent increase of tissue plasminogen activator concentration was observed. At maximal work-load the concentration was 2.3 +/- 1.9 (SD) IU/ml (9.9 +/- 8.1 ng/ml active enzyme), which after 10 min rest decreased to 26 +/- 12 (SD) % of the values at maximal work-load. In these samples only small amounts of plasmin-alpha 2-antiplasmin complex were detected, although the activator content was of the same order of magnitude as after venous occlusion.
Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
Fogari R, Preti P, Lazzari P, Corradi L, Zoppi A, Fogari E Eur J Clin Pharmacol. 2003; 59(4):271-5.
PMID: 12830340 DOI: 10.1007/s00228-003-0621-3.
Pinsky D, Liao H, Lawson C, Yan S, Chen J, Carmeliet P J Clin Invest. 1998; 102(5):919-28.
PMID: 9727060 PMC: 508957. DOI: 10.1172/JCI307.
Du TOIT P, van Aswegen C, Nel J, Steyn P, Ligthelm A, DU PLESSIS D Urol Res. 1995; 23(5):335-8.
PMID: 8839391 DOI: 10.1007/BF00300023.
Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.
Gray R, Yudkin J, PATTERSON D Br Heart J. 1993; 69(3):228-32.
PMID: 8461220 PMC: 1024985. DOI: 10.1136/hrt.69.3.228.
The effect of different exercise intensities on the fibrinolytic system.
Molz A, Heyduck B, Lill H, Spanuth E, Rocker L Eur J Appl Physiol Occup Physiol. 1993; 67(4):298-304.
PMID: 8299595 DOI: 10.1007/BF00357626.